Parkinson’s infusion treatment demonstrates advantage over oral delivery
European Pharmaceutical Review
MARCH 18, 2024
A Phase III trial has shown that compared oral drug delivery, administering levodopa through an infusion pump led to nearly two hours of day (1.72) of additional time in which the medicine reduced symptoms in Parkinson’s patients. There were 381 Parkinson’s patients enrolled in the trial. and Joan A.
Let's personalize your content